Discuss This Disease

4 free views remaining today

Usher syndrome type 1J

ICD-10 Codes

Related ICD-10:

Description

Usher Syndrome Type 1J: A Rare Genetic Disorder

Usher syndrome type 1J is a rare genetic disorder that affects both hearing and vision. It is characterized by congenital, bilateral, profound sensorineural hearing loss, vestibular areflexia, and adolescent-onset retinitis pigmentosa (RP) [2].

Key Features:

  • Deafness: Profound deafness or hearing loss at birth
  • Balance Issues: Severe balance problems that cause trouble sitting or

Additional Characteristics

  • Profound sensorineural hearing loss
  • Balance issues
  • Deafness
  • Vestibular areflexia
  • Adolescent-onset retinitis pigmentosa (RP)

Signs and Symptoms

Common Signs and Symptoms of Usher Syndrome Type 1J

Usher syndrome type 1J is a rare genetic disorder that affects both hearing and vision. The main symptoms of this condition are:

  • Congenital, bilateral, profound sensorineural hearing loss: This means that individuals with Usher syndrome type 1J are born with severe to profound hearing loss in both ears.
  • Vestibular areflexia: This refers to a lack of response or balance problems due to impaired vestibular function.
  • Adolescent-onset retinitis pigmentosa (RP): RP is a disorder that affects the retina, leading to progressive vision loss. In Usher syndrome type 1J, RP typically begins in adolescence.

Additional Symptoms

While not universal, some individuals with Usher syndrome type 1J may also experience:

  • Vision loss: This can range from mild to severe and may progress over time.
  • Balance problems: Some people with Usher syndrome type 1J may have difficulty with balance or coordination due to impaired vestibular function.

Important Note

It's essential to note that the symptoms of Usher syndrome type 1J can vary in severity and onset, even among individuals within the same family. If you suspect you or a loved one has this condition, consult a healthcare professional for proper diagnosis and guidance.

References:

  • [3] - Type 1: Children with type 1 Usher syndrome have normal hearing at birth.
  • [5] - Symptoms depend on the type of Usher syndrome. But they often include problems with hearing or deafness, balance, and eyesight or blindness.
  • [9] - The main symptoms of Usher syndrome are deafness or hearing loss and RP. Different types of Usher syndrome cause different symptoms, but everyone with Usher syndrome develops RP.
  • [13] - Symptoms of Usher syndrome differ depending on which type you have. Depending on the type of Usher syndrome, vision loss can begin at birth or in early to mid-adulthood.
  • [15] - Usher syndrome type I (USH1) is characterized by congenital, bilateral, profound sensorineural hearing loss, vestibular areflexia, and adolescent-onset retinitis pigmentosa (RP).

Additional Symptoms

  • Balance problems
  • Adolescent-onset retinitis pigmentosa (RP)
  • Congenital, bilateral, profound sensorineural hearing loss
  • loss of vision
  • areflexia

Diagnostic Tests

Diagnostic Tests for Usher Syndrome Type 1J

Usher syndrome type 1J, a rare genetic disorder, requires specific diagnostic tests to confirm the condition. The following tests are commonly used to diagnose Usher syndrome type 1J:

  • **Electronystagmography (

Additional Diagnostic Tests

  • Genetic testing
  • Electroretinogram (ERG)
  • Electronystagmography (ENG)
  • Visual field testing
  • Auditory brainstem response (ABR) test

Treatment

Current Drug Treatments for Usher Syndrome Type 1J

Usher syndrome type 1J is a rare genetic disorder that causes severe to profound bilateral congenital sensorineural hearing loss and blindness from retinitis pigmentosa (RP). While there is no cure for this condition, researchers are exploring various drug treatments to manage its symptoms.

Investigational RNA Therapy: QR-421a

One promising area of research is the use of investigational RNA therapy, specifically QR-421a. This first-in-class treatment targets the underlying cause of vision loss associated with Usher syndrome (USH2A) and has shown positive results in clinical trials [9][11]. The Phase 1/2 Stellar trial demonstrated that QR-421a is effective and safe for treating Usher syndrome and retinitis pigmentosa (RP) due to mutation(s) in exon 13 of the USH2A gene.

Other Potential Treatments

While there are no specific drug treatments mentioned for Usher syndrome type 1J, researchers have explored various therapies for managing its symptoms. These include:

  • Cochlear implants and hearing aids to address hearing loss [1][7]
  • Supportive visual measures to help individuals with RP [7]
  • Optimisation of development and supportive care to improve quality of life [7]

Future Research Directions

Further research is needed to develop effective drug treatments for Usher syndrome type 1J. Ongoing clinical trials, such as the Phase 3 trial of N-acetylcysteine (NAC) for retinitis pigmentosa (RP), may provide valuable insights into potential therapeutic options [8].

References

[1] Current Trials and Pre-clinical Studies for Usher Syndrome Treatment. [7] Is there any treatment? · 1) Cochlear implantation and hearing aids · 2) Supportive visual measures · 3) Optimisation of development and ... [8] Oct 7, 2024 — Johns Hopkins University (JHU) has launched a Phase 3 clinical trial of N-acetylcysteine (NAC) for the treatment of retinitis pigmentosa (RP). [9] QR-421a is a first-in-class investigational RNA-based oligonucleotide designed to address the underlying cause of the vision loss associated with Usher syndrome ... [11] March 2021 Update: ProQR has published positive results from its Phase 1/2 Stellar trial of QR-421a, an investigational RNA therapy for the treatment of Usher syndrome and retinitis pigmentosa (RP) due to mutation(s) in exon 13 of the USH2A gene.

Recommended Medications

  • N-acetylcysteine (NAC)
  • Cochlear implants
  • QR-421a
  • Heating aids
  • Supportive visual measures

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Differential Diagnosis of Usher Syndrome Type 1J

Usher syndrome type 1J is a rare genetic disorder characterized by congenital, bilateral, profound sensorineural hearing loss, vestibular areflexia, and adolescent-onset retinitis pigmentosa (RP). When diagnosing this condition, it's essential to consider differential diagnoses that may present similar symptoms.

Possible Differential Diagnoses:

  • Nonsyndromic Hearing Loss: This is a type of hearing loss that occurs in the absence of any other medical conditions. It can be caused by genetic mutations or environmental factors.
  • Deafness-Dystonia-Optic Nerve Degeneration Syndrome: This is a rare genetic disorder characterized by deafness, dystonia (a movement disorder), and optic nerve degeneration.
  • Retinitis Pigmentosa: While Usher syndrome type 1J is associated with RP, it's essential to consider this condition as a separate entity when diagnosing patients.

Clinical Features to Consider:

When differentiating between these conditions, the following clinical features should be considered:

  • Age of onset: Usher syndrome type 1J typically presents with congenital hearing loss and adolescent-onset RP.
  • Type and severity of hearing loss: Profound sensorineural hearing loss is a hallmark of Usher syndrome type 1J.
  • Vestibular function: Vestibular areflexia is a characteristic feature of Usher syndrome type 1J.

Diagnostic Tools:

To confirm the diagnosis of Usher syndrome type 1J, genetic testing and clinical evaluation by an expert in genetics or ophthalmology may be necessary. Next-generation sequencing (NGS)-based testing can provide most analyzed USH patients with a molecular diagnosis [10].

References:

  • [9] Apr 29, 2024 — Genetic Testing: Definitive diagnosis of Usher Syndrome type 1 ...
  • [10] Usher syndrome (USH) manifests with congenital and apparently isolated hearing loss, followed by retinal degeneration in later life. Therefore, and because of its high prevalence in the congenitally hearing-impaired population, USH is one of the most relevant deafness syndromes.
  • [14] Usher syndrome type 1 (Usher 1) is the most severe subtype in which patients exhibit severe to profound bilateral congenital sensorineural hearing loss (), most frequently non-progressive, with vestibular areflexia.

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_5173
owl#annotatedSource
t370505
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#hasDbXref
MIM:614869
oboInOwl#id
DOID:0110836
core#notation
DOID:0110836
IAO_0000115
An Usher syndrome type 1 that has_material_basis_in caused by homozygous mutation in the CIB2 gene on chromosome 15q24.
oboInOwl#hasExactSynonym
Usher syndrome type IJ
rdf-schema#label
Usher syndrome type 1J
rdf-schema#subClassOf
t370316
IDO_0000664
http://purl.obolibrary.org/obo/GENO_0000148
relatedICD
http://example.org/icd10/H35.5
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.